Rama Pichika - Publications

Affiliations: 
1999-2001 University of Michigan Medical School, Ann Arbor, MI, United States 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Pichika R, Kuruvilla SA, Patel N, Vu K, Sinha S, Easwaramoorthy B, Narayanan TK, Shi B, Christian B, Mukherjee J. Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET. Nuclear Medicine and Biology. 40: 117-25. PMID 23141552 DOI: 10.1016/J.Nucmedbio.2012.09.009  0.475
2012 Pichika R, Taha AY, Gao F, Kotta K, Cheon Y, Chang L, Kiesewetter D, Rapoport SI, Eckelman WC. The synthesis and in vivo pharmacokinetics of fluorinated arachidonic acid: implications for imaging neuroinflammation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1383-91. PMID 22851635 DOI: 10.2967/Jnumed.112.105734  0.465
2012 Pichika R, Buchsbaum MS, Bailer U, Hoh C, Decastro A, Buchsbaum BR, Kaye W. Serotonin transporter binding after recovery from bulimia nervosa. The International Journal of Eating Disorders. 45: 345-52. PMID 21671458 DOI: 10.1002/Eat.20944  0.368
2011 Pichika R, Easwaramoorthy B, Christian BT, Shi B, Narayanan TK, Collins D, Mukherjee J. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine). Nuclear Medicine and Biology. 38: 1183-92. PMID 21831652 DOI: 10.1016/J.Nucmedbio.2011.05.005  0.454
2010 Pichika R, Jewett DM, Sherman PS, Traynor JR, Husbands SM, Woods JH, Kilbourn MR. Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists. Nuclear Medicine and Biology. 37: 989-96. PMID 21055630 DOI: 10.1016/J.Nucmedbio.2010.06.002  0.329
2010 Nguyen VL, Pichika R, Bhakta PH, Kant R, Mukherjee J. (R)-N-Methyl-3-(3'-[F]fluoropropyl)phenoxy)-3-phenylpropanamine (F-MFP3) as a potential PET imaging agent for norepinephrine transporter. Journal of Labelled Compounds & Radiopharmaceuticals. 53: 172-177. PMID 20495670 DOI: 10.1002/Jlcr.1744  0.459
2007 Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. Synapse (New York, N.Y.). 61: 29-36. PMID 17068780 DOI: 10.1002/syn.20338  0.391
2006 Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 1697-706. PMID 17015907  0.51
2006 Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nuclear Medicine and Biology. 33: 295-304. PMID 16631077 DOI: 10.1016/j.nucmedbio.2005.12.017  0.479
2005 Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 130-40. PMID 15632043  0.417
Show low-probability matches.